SELF-BREATHE RCT for Chronic Breathlessness
Launched by KING'S COLLEGE HOSPITAL NHS TRUST · Oct 1, 2020
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults ≥ 18 years of age, with the ability to read and type in English
- • Access to a computer, or tablet or smart phone, with internet access and the ability to email
- • Chronic breathlessness (CB) defined as; breathlessness that persists (\>3months) despite optimal pharmacological treatment of the underlying disease including cancer, chronic obstructive pulmonary disease (COPD),asthma, interstitial lung disease (ILD), bronchiectasis, cystic fibrosis (CF) chronic heart failure (CHF), sickle cell disease, chronic renal/ liver failure or post COVID-19
- • Chronic breathlessness at rest or on exertion; MRC dysponea score \>2
- • Willing to engage with short-term self-guided internet-based breathlessness intervention (SELF-BREATHE)
- • Able to provide informed consent
- Exclusion Criteria:
- • Breathlessness of unknown cause
- • A primary diagnosis of chronic hyperventilation syndrome
- • Currently participating in a rehabilitation programme, e.g. pulmonary/cardiac rehabilitation
About King's College Hospital Nhs Trust
King's College Hospital NHS Trust is a leading healthcare institution in the United Kingdom, renowned for its commitment to providing high-quality patient care and advancing medical research. With a strong emphasis on clinical excellence, the Trust supports a wide range of clinical trials across various specialties, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. By fostering innovation and collaboration, King's College Hospital NHS Trust aims to enhance treatment options and improve outcomes for patients, while contributing to the global body of medical knowledge through rigorous scientific investigation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials